Kyverna Therapeutics Inc. (KYTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Kyverna Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$5.89
+4.62% today
Market cap
$348M
Overall quality
—
Kronos AI 30-day
+36.2%
8 of 8 simulated paths end higher
Kyverna Therapeutics Inc. (KYTX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $348M. It trades at $5.89, up 4.62% today. 4 analysts' average target of $30.33 implies +414.9% from today's price. Kronos AI's 30-day forecast is +36.2% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $30.33 |
| Low – high | $25.00 – $33.00 |
| Analysts | 4 |
| Upside to average | +414.9% |
Kronos AI 30-day forecast
| Expected close | $7.67 (+36.2%) |
| Likely range | +28.5% … +43.2% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.